Detailed View
PACB - Pacific Biosciences of Californ
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
728,898,112
Adj EBIT (TTM)
-133,041,000
Enterprise Value
492,025,112
Last Price
2.35
Earnings Yield
-27.04%
Return on Capital
-37.77%
Capital
352,199,000
1Y Price Chart
Last Price: $2.35
1Y Change: 20.88%
As of 2026-11-02 | 1Y Change: 20.88%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 39,007,000 | -44,610,000 |
| 2026-03-31 | 10-Q | 2026 | 37,178,000 | -8,357,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 44,645,000 | -41,197,000 |
| 2025-09-30 | 10-Q | 2025 | 38,441,000 | -38,877,000 |
| 2025-06-30 | 10-Q | 2025 | 39,766,000 | -44,853,000 |
| 2025-03-31 | 10-Q | 2025 | 37,153,000 | -428,934,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 39,224,000 | -32,104,000 |
| 2024-09-30 | 10-Q | 2024 | 39,967,000 | -64,077,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.